Treatment selection for uveal melanoma

Developments in Ophthalmology

Volumn 49, Issue , 2012, Pages 16-26

  Damato, Bertil E ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; HUMAN; MELANOMA; METASTASIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; UVEA MELANOMA; UVEA TUMOR;

COMBINED MODALITY THERAPY; DECISION MAKING; HUMANS; MELANOMA; NEOPLASM METASTASIS; UVEAL NEOPLASMS;

EID: 84925933019     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000328251     Document Type: Article

References (20)

1. Damato B: Does ocular treatment of uveal melanoma influence survival? Br J Cancer 2010;103:285-290.
2. Damato BE, Dopierala JA, Coupland SE: Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 2010;16:6083-6092.
3. Callejo S, Coupland SE, Damato B: Sudden growth of a choroidal melanoma and multiplex ligationdependent probe amplification findings suggesting late transformation to monosomy 3 type. Arch Ophthalmol 2011;129:958-960.
4. Damato B, Coupland SE: A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye (Lond) 2009;23:2152-2160.
5. Parrella P, Sidransky D, Merbs SL: Allelotype of posterior uveal melanoma: Implications for a bifurcated tumor progression pathway. Cancer Res 1999;59: 3032-3037.
6. Kaiserman N, Kaiserman I, Hendler K, Frenkel S, Pe'er J: Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas. Br J Ophthalmol 2009;93:1167-1171.
7. Van Ginderdeuren R, Van Limbergen E, Spileers W: 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma. Br J Ophthalmol 2005;89: 1306-1310.
8. Finger PT, Chin KJ, Duvall G: Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology 2009; 116(4):790-796.
9. Gragoudas ES: Proton beam irradiation of uveal melanomas: The first 30 years. The Weisenfeld Lecture. Invest Ophthalmol Vis Sci 2006;47:4666-4673.
10. Damato B, Patel I, Campbell IR, Mayles HM, Errington RD: Local tumor control after (106)Ru brachytherapy of choroidal melanoma. Int J Radiat Oncol Biol Phys 2005;63:385-391.
11. Hadden PW, Hiscott PS, Damato BE: Histopathology of eyes enucleated after endoresection of choroidal melanoma. Ophthalmology 2004;111:154-160.
12. Damato B, Wong D, Green FD, Mackenzie JM: Intrascleral recurrence of uveal melanoma after transretinal 'endoresection'. Br J Ophthalmol 2001; 85:114-115.
13. Dunavoelgyi R, Dieckmann K, Gleiss A, et al: Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. Int J Radiat Oncol Biol Phys 2010, E-pub ahead of print.
14. Damato EM, Damato B, Sibbring JS, Coupland SE: Ciliary body melanoma with partial deletion of chromosome 3 detected with multiplex ligationdependent probe amplification. Graefes Arch Clin Exp Ophthalmol 2008;246:1637-1640.
15. Damato B, Kacperek A, Chopra M, Sheen MA, Campbell IR, Errington RD: Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys 2005;63:109-115.
16. Tan AN, Hoevenaars JG, Webers CA, Damato B, Beckers HJ: Baerveldt implant for secondary glaucoma due to iris melanoma. Clin Ophthalmol 2010; 4:407-409.
17. Shields CL, Naseripour M, Shields JA, Freire J, Cater J: Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: Tumor control and ocular complications. Am J Ophthalmol 2003; 135:648-656.
18. Cook SA, Damato B, Marshall E, Salmon P: Reconciling the principle of patient autonomy with the practice of informed consent: Decision-making about prognostication in uveal melanoma. Health Expect 2010, E-pub ahead of print.
19. Ah-Fat FG, Sharma MC, Damato BE: Taping outpatient consultations: A survey of attitudes and responses of adult patients with ocular malignancy. Eye 1998;12:789-791.
20. Damato B: Legacy of the collaborative ocular melanoma study. Arch Ophthalmol 2007;125:966-968.